伟思医疗
(688580)
| 流通市值：29.49亿 | | | 总市值：29.49亿 |
| 流通股本：9577.13万 | | | 总股本：9577.13万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 627,053,203.57 | 1,027,846,530.53 | 1,114,688,351.56 | 1,154,989,792.54 |
| 应收票据及应收账款 | 37,105,103.52 | 39,761,185.24 | 36,730,380.92 | 36,620,133.9 |
| 应收账款 | 37,105,103.52 | 39,761,185.24 | 36,730,380.92 | 36,620,133.9 |
| 预付款项 | 6,794,940.26 | 6,926,509.8 | 7,703,743.92 | 5,798,482.19 |
| 其他应收款合计 | 6,680,688.18 | 5,353,215.03 | 6,105,919.66 | 4,897,136.65 |
| 存货 | 38,689,575.59 | 44,511,691.66 | 41,273,617.42 | 39,916,747.46 |
| 其他流动资产 | 20,727,458.18 | 17,003,721.13 | 15,730,041.22 | 12,605,716.69 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,137,050,969.3 | 1,141,402,853.39 | 1,222,232,054.7 | 1,254,828,009.43 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 22,035,950.26 | 22,035,950.26 | 22,035,950.26 | 22,035,950.26 |
| 固定资产 | 89,659,419.08 | 91,879,055.34 | 93,720,938.43 | 96,076,595.89 |
| 在建工程 | 300,559,120.71 | 273,098,697.81 | 242,412,758.15 | 224,859,149.68 |
| 使用权资产 | 506,815.65 | 557,497.23 | 299,073.35 | 596,480.39 |
| 无形资产 | 103,162,228.45 | 104,666,728.3 | 107,680,373.02 | 109,082,075.12 |
| 开发支出 | 21,574,007.39 | 18,355,677.23 | 14,915,963.56 | 11,492,200.66 |
| 商誉 | 69,306,067.79 | 69,306,067.79 | 69,306,067.79 | 69,306,067.79 |
| 长期待摊费用 | 2,354,238.24 | 2,635,495.11 | 2,618,263.66 | 1,249,177.01 |
| 递延所得税资产 | 19,161,878.92 | 18,721,302.51 | 17,837,120.98 | 15,103,129.91 |
| 其他非流动资产 | 10,033,474.63 | 1,289,461.73 | 3,465,867.14 | 1,395,205 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 638,353,201.12 | 602,545,933.31 | 574,292,376.34 | 551,196,031.71 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,775,404,170.42 | 1,743,948,786.7 | 1,796,524,431.04 | 1,806,024,041.14 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 12,433,483.32 | 19,177,865.98 | 14,012,115.94 | 17,956,791.32 |
| 应付账款 | 12,433,483.32 | 19,177,865.98 | 14,012,115.94 | 17,956,791.32 |
| 预收款项 | 873,549.7 | 930,407.61 | 1,284,437.86 | 1,192,476.71 |
| 合同负债 | 3,291,266.27 | 3,642,199.24 | 2,871,722.07 | 5,082,723.52 |
| 应付职工薪酬 | 8,743,417.8 | 9,217,331.64 | 9,904,440.03 | 24,198,485.23 |
| 应交税费 | 12,029,130.4 | 9,415,322.33 | 16,768,117.36 | 19,630,474.48 |
| 其他应付款合计 | 94,772,519.17 | 95,895,615.83 | 71,151,091.26 | 83,533,836.27 |
| 其他流动负债 | - | - | 35,849 | 88,215.93 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 132,143,366.66 | 138,278,742.63 | 116,027,773.52 | 151,683,003.46 |
| 非流动负债: | | | | |
| 租赁负债 | 450,103.58 | 507,787.43 | - | - |
| 长期应付款 | 28,069,419.35 | 27,747,561.2 | 27,425,703.05 | 27,103,844.9 |
| 递延收益 | 2,090,564.97 | 3,361,843.22 | 3,741,285.94 | - |
| 递延所得税负债 | 432,155.84 | 448,687.82 | 465,260.82 | 481,973.83 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 31,042,243.74 | 32,065,879.67 | 31,632,249.81 | 27,585,818.73 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 163,185,610.4 | 170,344,622.3 | 147,660,023.33 | 179,268,822.19 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 95,771,288 | 95,771,288 | 68,623,867 | 68,623,867 |
| 资本公积 | 1,074,982,826.68 | 1,095,829,523.88 | 1,118,902,977.05 | 1,111,844,639.51 |
| 减:库存股 | 7,242,279.07 | 38,157,501.7 | 33,152,505.72 | 26,450,203.61 |
| 盈余公积 | 34,311,933.5 | 34,311,933.5 | 34,311,933.5 | 34,311,933.5 |
| 未分配利润 | 414,394,790.91 | 385,848,920.72 | 460,178,135.88 | 438,424,982.55 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,612,218,560.02 | 1,573,604,164.4 | 1,648,864,407.71 | 1,626,755,218.95 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,612,218,560.02 | 1,573,604,164.4 | 1,648,864,407.71 | 1,626,755,218.95 |
| 负债和股东权益合计 | 1,775,404,170.42 | 1,743,948,786.7 | 1,796,524,431.04 | 1,806,024,041.14 |
| 公告日期 | 2024-10-25 | 2024-08-29 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |